V Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,081
Closed -$256K 392
2023
Q1
$256K Sell
3,081
-463
-13% -$38.3K 0.05% 319
2022
Q4
$304K Sell
3,544
-268
-7% -$21.2K 0.06% 275
2022
Q3
$235K Sell
3,812
-560
-13% -$35.3K 0.05% 330
2022
Q2
$270K Sell
4,372
-49
-1% -$3.03K 0.05% 332
2022
Q1
$263K Buy
4,421
+1
+0% +$64 0.04% 370
2021
Q4
$321K Sell
4,420
-981
-18% -$67.6K 0.05% 344
2021
Q3
$377K Sell
5,401
-807
-13% -$56.7K 0.06% 319
2021
Q2
$424K Buy
6,208
+781
+14% +$52.1K 0.07% 309
2021
Q1
$351K Sell
5,427
-196
-3% -$12.6K 0.06% 317
2020
Q4
$328K Buy
+5,623
New +$339K 0.07% 292
2020
Q3
Sell
-6,157
Closed -$474K 231
2020
Q2
$474K Sell
6,157
-552
-8% -$42.3K 0.12% 192
2020
Q1
$502K Buy
6,709
+300
+5% +$20.7K 0.16% 148
2019
Q4
$406K Hold
6,409
0.15% 168
2019
Q3
$406K Buy
6,409
+120
+2% +$7.84K 0.15% 168
2019
Q2
$425K Buy
6,289
+303
+5% +$19.9K 0.16% 151
2019
Q1
$378K Buy
5,986
+136
+2% +$9.04K 0.15% 151
2018
Q4
$399K Sell
5,850
-1,625
-22% -$114K 0.2% 124
2018
Q3
$588K Sell
7,475
-210
-3% -$15.9K 0.27% 96
2018
Q2
$604K Sell
7,685
-282
-4% -$19.9K 0.34% 80
2018
Q1
$578K Buy
7,967
+128
+2% +$10.2K 0.31% 92
2017
Q4
$628K Buy
7,839
+444
+6% +$33.7K 0.32% 86
2017
Q3
$594K Buy
7,395
+177
+2% +$13.5K 0.3% 80
2017
Q2
$510K Sell
7,218
-66
-0.9% -$4.39K 0.24% 89
2017
Q1
$488K Sell
7,284
-291
-4% -$20.5K 0.3% 87
2016
Q4
$545K Sell
7,575
-2,001
-21% -$149K 0.4% 76
2016
Q3
$760K Sell
9,576
-17,439
-65% -$1.42M 0.61% 54
2016
Q2
$2.28M Buy
27,015
+555
+2% +$49.3K 1.87% 4
2016
Q1
$2.44M Buy
+26,460
New +$2.39M 1.95% 7

Other funds holding GILD

V Wealth Advisors's GILD Position: Q2 2023 in Review

V Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2023, closing a stake of 3,081 shares — an estimated $256K sold.

V Wealth Advisors first reported a position in GILD in Q1 2016 and held it in 28 quarters. The position peaked at $2.44M in Q1 2016. 1,701 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • V Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2023 after selling out during the quarter.
  • V Wealth Advisors sold 3,081 Gilead Sciences shares in Q2 2023, an estimated $256K.
  • V Wealth Advisors first reported a position in Gilead Sciences in Q1 2016 and held it in 28 quarters.
  • V Wealth Advisors's Gilead Sciences position peaked at $2.44M in Q1 2016.
  • 1,701 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on V Wealth Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.